Skip to content

Cytokinetics CYTK Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.2×-0.6×
Eli Lilly logo
Eli LillyLLY
1.4×-1.1×
Merck & Co. logo
Merck & Co.MRK
1.1×+0.3×
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
0.2×+0.1×
Medtronic logo
MedtronicMDT
0.6×0.0×
Boston Scientific logo
Boston ScientificBSX
-0.5×

Other financials

Income statement

See full
Revenue$19.4M+1,126%
Operating income-$183.6M-18.0%
Net income-$206.0M-27.7%
EPS (diluted)-$1.67-22.8%

Balance sheet

See full
Cash & equivalents$129.8M+76.2%
Total debt$418.2M+75.8%
Total equity-$826.6M-210%
Total assets$1.3B+0.7%

Cash flow

See full
Operating cash flow-$145.5M-10.5%
CapEx$5.9M+4.7%
Free cash flow-$151.4M-10.3%

Valuation

See full
Market cap$10.7B+70.6%
Enterprise value$10.98B+70.7%
P/S101.1×-225×

Profitability

See full
Operating margin-605.1%-268pp
Net margin-784%-337pp
FCF margin-518.8%-223pp

Returns & leverage

See full
Return on equity-337.6%
Current ratio4.2×-1.8×

Where this comes from

Calculated from Cytokinetics’s reported figures.

Based on the most recent quarter.

The official record: Cytokinetics’s 10-Q, filed August 9, 2024, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cytokinetics's debt-to-equity?
Cytokinetics (CYTK) reported debt-to-equity of 2.2× in Q2 2024.
What does debt-to-equity mean?
How much debt the company carries for every dollar of shareholder equity.
How do you interpret debt-to-equity?
Lower is generally safer, but moderate leverage can boost returns. Read in the context of cash-flow stability — a utility tolerates more debt than a cyclical. Negative equity makes the ratio meaningless and it is suppressed there.
How does debt-to-equity compare across companies?
Comparable within an industry; capital structures differ sharply across sectors. Not meaningful for banks.